248 related articles for article (PubMed ID: 37933387)
1. Mesoporous silica/organosilica nanoparticles for cancer immunotherapy.
Theivendran S; Lazarev S; Yu C
Exploration (Beijing); 2023 Jun; 3(3):20220086. PubMed ID: 37933387
[TBL] [Abstract][Full Text] [Related]
2. Mesoporous Silica and Organosilica Nanoparticles: Physical Chemistry, Biosafety, Delivery Strategies, and Biomedical Applications.
Croissant JG; Fatieiev Y; Almalik A; Khashab NM
Adv Healthc Mater; 2018 Feb; 7(4):. PubMed ID: 29193848
[TBL] [Abstract][Full Text] [Related]
3. Organosilica Nanoparticles and Medical Imaging.
Nakamura M
Enzymes; 2018; 44():137-173. PubMed ID: 30360813
[TBL] [Abstract][Full Text] [Related]
4. Mesoporous Silica and Organosilica Nanomaterials as UV-Blocking Agents.
Knežević NŽ; Ilić N; D Okić V; Petrović R; Janaćković DOE
ACS Appl Mater Interfaces; 2018 Jun; 10(24):20231-20236. PubMed ID: 29863843
[TBL] [Abstract][Full Text] [Related]
5. Overview of stimuli-responsive mesoporous organosilica nanocarriers for drug delivery.
Guimarães RS; Rodrigues CF; Moreira AF; Correia IJ
Pharmacol Res; 2020 May; 155():104742. PubMed ID: 32151682
[TBL] [Abstract][Full Text] [Related]
6. Degradability and Clearance of Silicon, Organosilica, Silsesquioxane, Silica Mixed Oxide, and Mesoporous Silica Nanoparticles.
Croissant JG; Fatieiev Y; Khashab NM
Adv Mater; 2017 Mar; 29(9):. PubMed ID: 28084658
[TBL] [Abstract][Full Text] [Related]
7. Syntheses and applications of periodic mesoporous organosilica nanoparticles.
Croissant JG; Cattoën X; Wong MC; Durand JO; Khashab NM
Nanoscale; 2015 Dec; 7(48):20318-34. PubMed ID: 26585498
[TBL] [Abstract][Full Text] [Related]
8. Mesoporous Organosilica Nanoparticles to Fight Intracellular Staphylococcal Aureus Infections in Macrophages.
Jambhrunkar M; Maghrebi S; Doddakyathanahalli D; Wignall A; Prestidge CA; Bremmell KE
Pharmaceutics; 2023 Mar; 15(4):. PubMed ID: 37111523
[TBL] [Abstract][Full Text] [Related]
9. Mesoporous Silica Materials as an Emerging Tool for Cancer Immunotherapy.
Escriche-Navarro B; Escudero A; Lucena-Sánchez E; Sancenón F; García-Fernández A; Martínez-Máñez R
Adv Sci (Weinh); 2022 Sep; 9(26):e2200756. PubMed ID: 35866466
[TBL] [Abstract][Full Text] [Related]
10. Ultrasmall mesoporous organosilica nanoparticles: Morphology modulations and redox-responsive biodegradability for tumor-specific drug delivery.
Yu L; Chen Y; Lin H; Du W; Chen H; Shi J
Biomaterials; 2018 Apr; 161():292-305. PubMed ID: 29427925
[TBL] [Abstract][Full Text] [Related]
11. Antibody-activated trans-endothelial delivery of mesoporous organosilica nanomedicine augments tumor extravasation and anti-cancer immunotherapy.
Huang T; Li S; Fang J; Li F; Tu S
Bioact Mater; 2021 Jul; 6(7):2158-2172. PubMed ID: 33511314
[TBL] [Abstract][Full Text] [Related]
12. Mesoporous Silica as a Versatile Platform for Cancer Immunotherapy.
Nguyen TL; Choi Y; Kim J
Adv Mater; 2019 Aug; 31(34):e1803953. PubMed ID: 30417454
[TBL] [Abstract][Full Text] [Related]
13. Biomimetic Redox-Responsive Mesoporous Organosilica Nanoparticles Enhance Cisplatin-Based Chemotherapy.
Chen F; Zhang F; Wang Y; Peng J; Cao L; Mei Q; Ge M; Li L; Chen M; Dong WF; Chang Z
Front Bioeng Biotechnol; 2022; 10():860949. PubMed ID: 35372319
[TBL] [Abstract][Full Text] [Related]
14. Multifunctional Gold-Mesoporous Silica Nanocomposites for Enhanced Two-Photon Imaging and Therapy of Cancer Cells.
Croissant JG; Qi C; Maynadier M; Cattoën X; Wong Chi Man M; Raehm L; Mongin O; Blanchard-Desce M; Garcia M; Gary-Bobo M; Durand JO
Front Mol Biosci; 2016; 3():1. PubMed ID: 26870736
[TBL] [Abstract][Full Text] [Related]
15. Biodegradable Oxamide-Phenylene-Based Mesoporous Organosilica Nanoparticles with Unprecedented Drug Payloads for Delivery in Cells.
Croissant JG; Fatieiev Y; Julfakyan K; Lu J; Emwas AH; Anjum DH; Omar H; Tamanoi F; Zink JI; Khashab NM
Chemistry; 2016 Oct; 22(42):14806-14811. PubMed ID: 27258139
[TBL] [Abstract][Full Text] [Related]
16. Exogenous/Endogenous-Triggered Mesoporous Silica Cancer Nanomedicine.
Yang B; Chen Y; Shi J
Adv Healthc Mater; 2018 Oct; 7(20):e1800268. PubMed ID: 29938917
[TBL] [Abstract][Full Text] [Related]
17. Chemistry of Mesoporous Organosilica in Nanotechnology: Molecularly Organic-Inorganic Hybridization into Frameworks.
Chen Y; Shi J
Adv Mater; 2016 May; 28(17):3235-72. PubMed ID: 26936391
[TBL] [Abstract][Full Text] [Related]
18. Large Pore Mesoporous Silica and Organosilica Nanoparticles for Pepstatin A Delivery in Breast Cancer Cells.
Rahmani S; Budimir J; Sejalon M; Daurat M; Aggad D; Vivès E; Raehm L; Garcia M; Lichon L; Gary-Bobo M; Durand JO; Charnay C
Molecules; 2019 Jan; 24(2):. PubMed ID: 30658511
[TBL] [Abstract][Full Text] [Related]
19. Facile Synthesis of Three Types of Mesoporous Silica Microspheres as Drug Delivery Carriers and their Sustained-Release Properties.
Zhu Y; Wang B; Chen J; He J; Qiu X
Curr Drug Deliv; 2023; 20(9):1337-1350. PubMed ID: 35713141
[TBL] [Abstract][Full Text] [Related]
20. Applications and Biocompatibility of Mesoporous Silica Nanocarriers in the Field of Medicine.
Zhang C; Xie H; Zhang Z; Wen B; Cao H; Bai Y; Che Q; Guo J; Su Z
Front Pharmacol; 2022; 13():829796. PubMed ID: 35153797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
